• PDF / 167,299 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 0 Downloads / 252 Views

DOWNLOAD

REPORT

1173-5503/20/0861-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 5 Sep 2020 No. 861

1

Recommend Documents

Is LV dysfunction screening in childhood cancer survivors treated with anthracyclines and/or chest-directed RT cost effe

142 97 148KB

Which oesophageal cancer screening strategy is cost effective in China?

144 60 163KB

Is population genomic screening for breast/ovarian cancer cost effective?

101 72 163KB

Is childhood universal varicella vaccination cost effective in the UK?

167 69 163KB

Childhood cancer therapies cost effective in sub-Saharan Africa

148 45 167KB

MicroRNA-based screening cost effective in diagnosing gastric cancer

153 59 182KB

Kidney Disease in Childhood Cancer Survivors

192 52 11MB

Trastuzumab cost effective in early breast cancer

115 43 122KB

Preoperative lymphoscintigraphy cost effective in vulvar cancer

157 31 166KB

Exercise is more effective than health education in reducing fatigue in fatigued cancer survivors

183 110 440KB

Sleep intervention in infancy cost effective to reduce childhood obesity

161 16 163KB

Low-dose CT screening for lung cancer cost effective in smokers

179 11 182KB